Data Manipulation in Pharma
John discusses the troubling manipulation of data in pharmaceutical studies, highlighting the case of Vioxx, which was linked to increased risks of heart attacks and strokes. He reveals how Merck omitted critical data, impacting the study's conclusions and regulatory oversight. The conversation sheds light on the ethical challenges within clinical trials and the consequences of selective reporting.In this clip
From this podcast
Lex Fridman Podcast
John Abramson: Big Pharma | Lex Fridman Podcast #263
Related Questions